Profile data is unavailable for this security.
About the company
Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing a broad clinical development program with clinical trials in Europe, Australia and the U.S. The Company's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action.
- Revenue in NOK (TTM)0.00
- Net income in NOK-177.88m
- Incorporated2011
- Employees25.00
- LocationUltimovacs ASAUllernchausseen 64OSLO 0379NorwayNOR
- Websitehttps://ultimovacs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Opticept Technologies AB | 7.88m | -75.34m | 229.71m | 29.00 | -- | 0.6449 | -- | 29.16 | -2.26 | -2.26 | 0.2293 | 8.31 | 0.0193 | -0.061 | 4.94 | 267,517.30 | -18.54 | -41.76 | -20.15 | -46.21 | 125.86 | 62.65 | -959.65 | -882.41 | 0.6931 | -174.01 | 0.044 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
Lumito AB (publ) | 17.26k | -26.07m | 237.30m | 14.00 | -- | 2.43 | -- | 13,746.31 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
Exact Therapeutics AS | 0.00 | -48.33m | 237.40m | 8.00 | -- | 5.26 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
Thor Medical ASA | 0.00 | -5.56m | 239.56m | 1.00 | -- | 0.876 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Annexin Pharmaceuticals AB (publ) | 0.00 | -47.13m | 241.79m | 4.00 | -- | 26.39 | -- | -- | -0.1765 | -0.1765 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
Arctic Bioscience AS | 33.75m | -45.51m | 246.08m | 20.00 | -- | 0.9518 | -- | 7.29 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
Intervacc AB | 9.06m | -104.35m | 247.64m | 15.00 | -- | 1.11 | -- | 27.32 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Aqua Bio Technology ASA | 13.51m | -1.50m | 256.00m | 2.00 | -- | 11.90 | 295.74 | 18.95 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
Corline Biomedical AB | 21.70m | -4.57m | 269.51m | 13.00 | -- | 2.90 | -- | 12.42 | -0.2092 | -0.2092 | 0.9944 | 4.26 | 0.2089 | -- | 6.96 | 1,643,846.00 | -4.39 | -5.71 | -4.80 | -6.24 | 115.99 | 128.60 | -21.04 | -38.46 | -- | -235.63 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
InDex Pharmaceuticals Holding AB | 110.01m | -57.35m | 278.03m | 7.00 | -- | 1.16 | -- | 2.53 | -0.1037 | -0.1037 | 0.2028 | 0.443 | 0.3559 | -- | -- | 15,477,000.00 | -18.55 | -37.64 | -21.24 | -41.14 | -46.98 | -450.51 | -52.13 | -454.62 | -- | -- | 0.0086 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
SynAct Pharma AB | 0.00 | -193.79m | 295.85m | 5.00 | -- | 1.65 | -- | -- | -5.65 | -5.65 | 0.00 | 4.28 | 0.00 | -- | -- | 0.00 | -71.43 | -125.17 | -79.52 | -151.70 | -- | -- | -- | -- | -- | -853.13 | 0.0033 | -- | -- | -- | -117.54 | -- | -- | -- |
Ultimovacs ASA | 0.00 | -177.88m | 296.92m | 25.00 | -- | 1.15 | -- | -- | -5.17 | -5.17 | 0.00 | 7.53 | 0.00 | -- | -- | 0.00 | -44.31 | -28.80 | -50.09 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
Ascelia Pharma AB | 0.00 | -90.13m | 316.40m | 13.00 | -- | 5.12 | -- | -- | -2.63 | -2.63 | 0.00 | 1.80 | 0.00 | -- | -- | 0.00 | -65.17 | -- | -78.39 | -- | -- | -- | -- | -- | -- | -- | 0.2302 | -- | -- | -- | 16.72 | -- | -- | -- |
Bactiquant A/S | 18.84m | -20.06m | 350.79m | -- | -- | 15.90 | -- | 18.62 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Medivir AB | 7.85m | -98.01m | 353.87m | 10.00 | -- | 1.65 | -- | 45.06 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
INIFY Laboratories AB | 3.47m | -52.22m | 358.58m | 23.00 | -- | 4.83 | -- | 103.21 | -1.15 | -1.15 | 0.0768 | 1.64 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Nordea Investment Management AB (Norway)as of 30 Apr 2024 | 707.18k | 2.06% |
Handelsbanken Fonder ABas of 31 May 2024 | 436.38k | 1.27% |
KLP Kapitalforvaltning ASas of 31 Mar 2023 | 348.42k | 1.01% |
Folketrygdfondetas of 31 Dec 2023 | 343.47k | 1.00% |
Sissener ASas of 31 Dec 2023 | 300.00k | 0.87% |
Danske Invest Asset Management ASas of 30 Apr 2024 | 246.03k | 0.72% |
Equinor Asset Management ASAas of 31 Dec 2023 | 161.48k | 0.47% |
DNB Asset Management ASas of 30 Apr 2024 | 156.84k | 0.46% |
Storebrand Asset Management ASas of 31 Jan 2024 | 142.36k | 0.41% |
Dimensional Fund Advisors LPas of 31 Mar 2024 | 66.44k | 0.19% |